Pulse Biosciences, Inc. - ROE
PLSE
Price:
$25.6
Market Cap:
$1.77B
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2016-05-18
Stock Exchange
NASDAQ
Ticker
PLSE
PE Ratio
[-23.27]
ROE
[-86.67%]
Current Ratio
[7.26]
Dividend Yield
[0%]
Enterprise Value
[1.71B]
Dividend History
The ROE as of June 2026 (TTM) for Pulse Biosciences, Inc. (PLSE) is -86.67%
According to Pulse Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -86.67%. This represents a change of 289.98% compared to the average of -22.22% of the last 4 quarters.
Pulse Biosciences, Inc. (PLSE) Historical ROE (quarterly & annually)
How has PLSE ROE performed in the past?
The mean historical ROE of Pulse Biosciences, Inc. over the last ten years is 167.54%. The current -86.67% ROE has changed -151.73% with respect to the historical average. Over the past ten years (40 quarters), PLSE's ROE was at its highest in in the December 2022 quarter at 409.12%. The ROE was at its lowest in in the September 2022 quarter at -291.47%.
Average
167.54%
Median
-73.42%
Minimum
-217.25%
Maximum
2.60%
Pulse Biosciences, Inc. (PLSE) ROE by Quarter and Year
Discovering the peaks and valleys of Pulse Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 164.34%
Maximum Annual ROE = 2.60%
Minimum Annual Increase = -1559.07%
Minimum Annual ROE = -217.25%
| Year | ROE | Change |
|---|---|---|
| 2025 | -90.24% | 93.43% |
| 2024 | -46.65% | -50.97% |
| 2023 | -95.15% | -103.66% |
| 2022 | 2.60% | -1559.07% |
| 2021 | -178.37% | -17.90% |
| 2020 | -217.25% | 45.20% |
| 2019 | -149.62% | 164.34% |
| 2018 | -56.60% | 1.82% |
| 2017 | -55.59% | 47.74% |
| 2016 | -37.62% | 82.88% |
Pulse Biosciences, Inc. (PLSE) Average ROE
How has PLSE ROE performed in the past?
The current ROE of Pulse Biosciences, Inc. (PLSE) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-77.35%
5-year avg
438.43%
10-year avg
167.54%
Pulse Biosciences, Inc. (PLSE) ROE vs. Peers
How is PLSE’s ROE compared to its peers?
Pulse Biosciences, Inc.’s ROE is greater than STAAR Surgical Company (-6.07%), greater than LifeMD, Inc. (-172.30%), greater than Beta Bionics, Inc. (-23.00%), greater than Kestra Medical Technologies, Ltd. (-68.83%), greater than Immatics N.V. (-45.27%), greater than OPKO Health, Inc. (-16.78%), greater than Dianthus Therapeutics, Inc. (-1.78%), greater than Nektar Therapeutics (-87.00%), greater than NovoCure Limited (-50.82%), greater than Atai Beckley Inc. (-366.49%),
| Company | ROE | Market cap |
|---|---|---|
| -6.07% | $1.45B | |
| -172.30% | $229.72M | |
| -23.00% | $618.52M | |
| -68.83% | $1.16B | |
| -45.27% | $1.31B | |
| -16.78% | $1.07B | |
| -1.78% | $3.44B | |
| -87.00% | $1.19B | |
| -50.82% | $1.65B | |
| -366.49% | $1.49B |
Build a custom stock screener for Pulse Biosciences, Inc. (PLSE) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulse Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Pulse Biosciences, Inc. (PLSE) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Pulse Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Pulse Biosciences, Inc.'s ROE?
How is the ROE calculated for Pulse Biosciences, Inc. (PLSE)?
What is the highest ROE for Pulse Biosciences, Inc. (PLSE)?
What is the 3-year average ROE for Pulse Biosciences, Inc. (PLSE)?
What is the 5-year average ROE for Pulse Biosciences, Inc. (PLSE)?
How does the current ROE for Pulse Biosciences, Inc. (PLSE) compare to its historical average?